Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Health Disparities Subcommittee (HDS), 55566-55567 [E9-26054]

Download as PDF 55566 Federal Register / Vol. 74, No. 207 / Wednesday, October 28, 2009 / Notices Emphasis Panel; Ancillary Studies in Immunomodulation Clinical Trials. Date: November 17, 2009. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301– 402–7098, pamstad@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: October 21, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25878 Filed 10–27–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Meeting erowe on DSK5CLS3C1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of an Interagency Autism Coordinating Committee (IACC) meeting. The purpose of the IACC meeting is to discuss recommendations for the annual update of the IACC Strategic Plan for Autism Spectrum Disorders Research. The meeting will be open to the public and will be accessible by webcast and conference call. Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of Meeting: Open Full Committee Meeting. Date: November 10, 2009. Time: 9 a.m. to 5 p.m.* Eastern Time—* Approximate end time. Agenda: To discuss recommendations for the annual update of the IACC Strategic Plan for Autism Spectrum Disorder Research. Place: National Institute of Mental Health, 6001 Executive Boulevard, Neuroscience Center, Conference Rooms A1/A2, Rockville, MD 20852. Webcast Live: https://videocast.nih.gov/. Conference Call Access: Dial: 888–577–8995. Access code: 1991506. Cost: The meeting is free and open to the public. Registration: Pre-registration is recommended to expedite check-in. Seating VerDate Nov<24>2008 15:34 Oct 27, 2009 Jkt 220001 is limited to room capacity and on a first come, first served basis. Online preregistration will be available. Please visit the IACC Web site for pre-registration information: https://www.iacc.hhs.gov. Access: Metro accessible—Red Line— White Flint Metro Station. Contact Person: Ms. Lina Perez, Office of Autism Research Coordination, Office of the Director, National Institute of Mental Health, NIH, 6001 Executive Boulevard, NSC, Room 8200, Bethesda, MD 20892–9669, Phone: 301–443–6040, E-mail: IACCPublicInquiries@mail.nih.gov. Please Note: Any member of the public interested in presenting oral comments to the Committee must notify the Contact Person listed on this notice at least 5 days in advance of the meeting. Interested individuals and representatives of organizations must submit a letter of intent, a brief description of the organization represented, and a written/electronic copy of the oral presentation/statement by 5 p.m. ET, November 6, 2009. A printed/electronic copy of the comment/statement provided by the deadline is required prior to the oral presentation; the document will become a part of the public record. Only one representative of an organization will be allowed to present oral comments and presentations will be limited to three to five minutes per speaker, depending on number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in order of the date and time when their request to speak is received, along with the required written statement submitted in advance of the meeting by November 6 at 5 p.m. ET. In addition, any interested person may submit written comments to the IACC prior to the meeting by sending the statement to the Contact Person listed on this notice at least by 5 p.m. ET, November 6, 2009. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. All written statements received by the deadline for both oral and written public comment will be provided to the IACC for their consideration. The meeting will be open to the public through a conference call phone number and webcast live on the Internet. Individuals who participate in person or by using these electronic services and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request at least 7 days prior to the meeting. As a part of security procedures, attendees should be prepared to present a photo ID at the meeting registration desk during the check-in process. Pre-registration is recommended. Seating will be limited to the room capacity and seats will be on a first come, first served basis, with expedited check-in for those who are pre-registered. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. To access the webcast live on the Internet the following computer capabilities are PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 required: (A) Internet Explorer 5.0 or later, Netscape Navigator 6.0 or later or Mozilla Firefox 1.0 or later; (B) Windows® 2000, XP Home, XP Pro, 2003 Server or Vista; (C) Stable 56k, cable modem, ISDN, DSL or better Internet connection; (D) Minimum of Pentium 400 with 256 MB of RAM (Recommended); (E) Java Virtual Machine enabled (Recommended) Meeting schedule subject to change. This meeting is being published less than 15 days prior to the meeting due to the timing limitations for completing the updating of the Annual Strategic Plan for Autism Spectrum Disorder Research. Information about the IACC is available on the Web site: https://www.iacc.hhs.gov. Dated: October 22, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25991 Filed 10–27–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Child Health and Human Development Special Emphasis Panel, November 13, 2009, 10 a.m. to November 13, 2009, 4 p.m., National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD, 20852 which was published in the Federal Register on October 16, 2009, 74 FR 53278. The meeting date and time have been changed to November 16, 2009, 9 a.m. to November 16, 2009, 12 p.m. The meeting is closed to the public. Dated: October 20, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25955 Filed 10–27–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Health Disparities Subcommittee (HDS) Correction: This notice was published in the Federal Register on October 15, 2009, Volume 74, Number 198, Page E:\FR\FM\28OCN1.SGM 28OCN1 Federal Register / Vol. 74, No. 207 / Wednesday, October 28, 2009 / Notices 52968. The time, place, and public comment period of the ACD, CDC—HDS meeting has changed. The meeting will also be teleconferenced. Time: 2 p.m.–3:30 p.m. Place: CDC, 1600 Clifton Road, NE., Atlanta, GA 30333, Building 19, Room 247/ 248, Global Communication Center. To participate by teleconference, please dial 1– 800–369–2112 and enter passcode 4102105. Status: Open to the public; teleconference access limited only by availability of telephone ports. The public is welcome to participate during the public comments period which is tentatively scheduled from 3 to 3:15 p.m. EDT. Contact Person for More Information: Walter W. Williams, M.D., M.P.H., Designated Federal Officer, ACD, CDC—HDS, 1600 Clifton Road, NE., M/S E67, Atlanta, Georgia 30333. Telephone 404–498–2310, Email: www1@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: October 22, 2009. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–26054 Filed 10–27–09; 8:45 am] 55567 Agenda: To review and evaluate grant applications. Place: Nat’l Institute of Environmental Health Sciences, 530 Davis Drive, Morrisville, NC 27560 (Telephone Conference Call). Contact Person: Teresa Nesbitt, PhD, DVM, Chief, Scientific Review Branch, Division of Extramural Research and Training, Nat’l Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, (919) 541–7571, nesbittt@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Matters To Be Discussed: The agenda will include updates on Recovery Act activities and the draft guideline for prevention of intravascular catheter-related bloodstream infections, and discussion of infection control in ambulatory care settings. Agenda items are subject to change as priorities dictate. Contact Person For More Information: Michelle King, HICPAC, Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333 Telephone (404) 639– 2936. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 20, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dated: October 22, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25995 Filed 10–27–09; 8:45 am] [FR Doc. E9–25913 Filed 10–27–09; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) National Cancer Institute; Notice of Closed Meeting BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Healthcare Infection Control Practices Advisory Committee, (HICPAC) National Institutes of Health In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. erowe on DSK5CLS3C1PROD with NOTICES National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Conference Grant Review With An Environmental Health Focus. Date: November 20, 2009. Time: 1 p.m. to 3:30 p.m. VerDate Nov<24>2008 15:34 Oct 27, 2009 Jkt 220001 Times and Dates: 9 a.m.–5 p.m., November 12, 2009. 9 a.m.–12 p.m., November 13, 2009. Place: Washington Marriott at Metro Center, Salons C–D, 775 12th Street, NW., Washington, DC 20005, Telephone: (202) 737–2200. Status: Open to the public, limited only by the space available. Purpose: The Committee is charged with providing advice and guidance to the Secretary, HHS; the Assistant Secretary for Health, HHS; the Director, CDC; and the Director, National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), regarding: (1) The practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 Name of Committee: National Cancer Institute Special Emphasis Panel; Systems for Biomarker Research and Development. Date: November 23, 2009. Time: 11 a.m. to 1 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Suite 703, Room 7142, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Thomas M. Vollberg, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7142, Bethesda, MD 20892, 301–594–9582, vollbert@mail.nih.gov. E:\FR\FM\28OCN1.SGM 28OCN1

Agencies

[Federal Register Volume 74, Number 207 (Wednesday, October 28, 2009)]
[Notices]
[Pages 55566-55567]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26054]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC)--Health Disparities Subcommittee (HDS)

    Correction: This notice was published in the Federal Register on 
October 15, 2009, Volume 74, Number 198, Page

[[Page 55567]]

52968. The time, place, and public comment period of the ACD, CDC--HDS 
meeting has changed. The meeting will also be teleconferenced.

    Time: 2 p.m.-3:30 p.m.
    Place: CDC, 1600 Clifton Road, NE., Atlanta, GA 30333, Building 
19, Room 247/248, Global Communication Center. To participate by 
teleconference, please dial 1-800-369-2112 and enter passcode 
4102105.
    Status: Open to the public; teleconference access limited only 
by availability of telephone ports. The public is welcome to 
participate during the public comments period which is tentatively 
scheduled from 3 to 3:15 p.m. EDT.
    Contact Person for More Information: Walter W. Williams, M.D., 
M.P.H., Designated Federal Officer, ACD, CDC--HDS, 1600 Clifton 
Road, NE., M/S E67, Atlanta, Georgia 30333. Telephone 404-498-2310, 
E-mail: www1@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: October 22, 2009.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-26054 Filed 10-27-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.